Repetitive transcranial magnétic stimulation to treat substance use disorders and compulsive behavior

CNS and Neurological Disorders - Drug Targets

Volumn 14, Issue 3, 2015, Pages 331-340

  Protasio, Maria I B ^a   da Silva, João P L ^b   Arias Carrión, Oscar ^c   Nardi, Antonio E ^a,d   Machado, Sergio ^a,d,e   Cruz, Marcelo S ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

^b Institut Philippe Pinel de Montreal   (Canada)

^c HOSPITAL GENERAL DR MANUEL GEA GONZÁLEZ   (Mexico)

^d National Institute of Translational Medicine (INCT TM)   (Brazil)

^e SALGADO DE OLIVEIRA UNIVERSITY   (Brazil)

Author keywords

Alcohol; Binge eating; Cocaine; Compulsion; Gambling; Repetitive transcranial magnetic stimulation; Tobacco

Indexed keywords

COCAINE; NEUROTRANSMITTER;

ALCOHOL ABUSE; ARTICLE; BINGE EATING DISORDER; BRAIN FUNCTION; COMPULSION; DECISION MAKING; DORSOLATERAL PREFRONTAL CORTEX; FUNCTIONAL NEUROIMAGING; HEALTH PROGRAM; HUMAN; LIMBIC SYSTEM; MAGNETIC FIELD; MEMORY; MORTALITY; PATHOLOGICAL GAMBLING; PREFRONTAL CORTEX; RANDOMIZED CONTROLLED TRIAL (TOPIC); SEIZURE; SUBSTANCE USE; SUPERIOR FRONTAL GYRUS; TRANSCRANIAL MAGNETIC STIMULATION; WITHDRAWAL SYNDROME; COMPULSIVE BEHAVIOR; PATHOPHYSIOLOGY; PROCEDURES; SUBSTANCE-RELATED DISORDERS;

COMPULSIVE BEHAVIOR; CRAVING; HUMANS; PREFRONTAL CORTEX; RANDOMIZED CONTROLLED TRIALS AS TOPIC; SUBSTANCE-RELATED DISORDERS; TRANSCRANIAL MAGNETIC STIMULATION;

EID: 84929233770     PISSN: 18715273     EISSN: 19963181     Source Type: Journal    
DOI: 10.2174/1871527314666150318114043     Document Type: Article

References (104)

1. Nestler EJ, Malenka RC. The addicted brain. Sci Am 2004; 290(3): 78-85.
2. Potenza MN. The neurobiology of pathological gambling and drug addiction: an overview and new findings. Phil Trans R Soc B Biol Sci 2008; 363(1507): 3181-3189.
3. Wang GJ, Volkow ND, Thanos PK, Fowler JS. Similarity between obesity and drug addiction as assessed by neurofunctional imaging: a concept review. J Addict Dis 2004; 23(3): 39-53.
4. WHO. The world health report 2002 - Reducing Risks, Promoting Healthy Life. Acessed on: March 12th, 2014 [Available from: http://www.who.int/whr/2002/en/].
5. Rehm J, Samokhvalov AV, Shield KD. Global burden of alcoholic liver diseases. J Hepatol 2013; 59(1):160-8.
6. Oberg M, Woodward A, Jaakkola MS, Peruga A, Pruss-Ustun A. Global estimate of the burden of disease from second-hand smoke. Global estimate of the burden of disease from second-hand smoke, 2010.
7. Decramer M, Janssens W, Miravitlles M. Chronic obstructive pulmonary disease. Lancet 2012; 379(9823): 1341-51.
8. Frieden TR, Bloomberg MR. How to prevent 100 million deaths from tobacco. Lancet 2007; 369(9574): 1758-61.
9. Degenhardt L, Whiteford HA, Ferrari AJ, et al. Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet 2013; 382(9904): 1564-74.
10. UNODC. Asseced in http://www.unodc.org/documents/data-andanalysis/ WDR2011/World_Drug_Report_2011_ebook.pdf on September 22, 2013.
11. Pomara C, Cassano T, D'Errico S, et al. Data available on the extent of cocaine use and dependence: biochemistry, pharmacologic effects and global burden of disease of cocaine abusers. Curr Med Chem 2012; 19(33): 5647-57.
12. Hodgins DC, Stea JN, Grant JE. Gambling disorders. Lancet 2011; 378(9806): 1874-84.
13. Hudson JI, Hiripi E, Pope Jr HG, Kessler RC. The prevalence and correlates of eating disorders in the National Comorbidity Survey Replication. Biol Psychiatry 2007; 61(3): 348-358.
14. Hrabosky JI. Body image and binge-eating disorder in body image a handbook of science, practice, and prevention. Guilford Press 2011; 34: 296-304.
15. Davis C. Compulsive overeating as an addictive behavior: overlap between food addiction and binge eating disorder. Curr Obes Rep 2013; 2: 171-8.
16. th, 2013.
17. Reis AD, Laranjeira R. Tratamento farmacologico do uso da cocaina. Universidade Federal de Sao Paulo (UNIFESP). Unidade de Pesquisa em Alcool e Drogas (UNIAD): 2006.
18. Cruz MS, Vargens RW, de Leao Ramoa M. Crack. Uma abordagem multidisciplinar. Prevencao ao uso indevido de drogas, 2010; 2010: 8.
19. Andrada NC. Abuso e Dependencia: Crack. Projeto Diretrizes, 2011.
20. Wang GJ, Volkow ND, Thanos PK, Fowler JS. Similarity between obesity and drug addiction as assessed by neurofunctional imaging: a concept review. J Addict Dis 2004; 23(3): 39-53.
21. Johnson BA, Ait-Daoud N. Neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Psychopharmacology 2000; 149: 327-44.
22. Johnson BA. Update on neuropharmacological treatments for alcoholism: scientific basis and clinical findings. Biochem Pharmacol 2008; 75(1): 34-56.
23. George M, Wassermann EM, Kimbrell TA, et al. Mood improvement following daily left prefrontal repetitive transcranial magnetic stimulation in patients with depression: a placebocontrolled crossover trial. Am J Psychiatry 1997; 154(12): 1752-6.
24. Pascual-Leone A, Bartres-Faz D, Keenan JP. Transcranial magnetic stimulation: studying the brain-behavior relationship by induction of 'virtual lesions'. Phil Trans R Soc Lond Ser B Biol Sci 1999; 354(1387): 1229-38.
25. Fregni F, Pascual-Leone A. Estimulacao magnetica transcraniana: uma nova ferramenta para o tratamento da depressao? Rev Psiquiatr Clin 2001; 28(5): 253-65.
26. Hoffman RE, Hawkins KA, Gueorguieva R, et al. Transcranial magnetic stimulation of left temporoparietal cortex and medicationresistant auditory hallucinations. Arch Gen Psychiatry 2003; 60: 49-56.
27. Eichammer P, Johann M, Kharraz A, et al. High-frequency repetitive transcranial magnetic stimulation decreases cigarette smoking. J Clin Psychiatry 2003; 64(8): 951-3.
28. Rumi DO, Gattaz WF, Rigonatti SP, et al. Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study. Biol Psychiatry 2005; 57: 162-6.
29. Camprodon JA, Martinez-Raga J, Alonso-Alonso M, Shih MC, Leon AP. One session of high frequency repetitive transcranial magnetic stimulation (rTMS) to the right prefrontal cortex transiently reduces cocaine craving. Drug Alcohol Depend 2007; 86 (1): 91-94.
30. Cantello R, Rossi S, Varrasi C, et al. Slow Repetitive TMS for Drug resistant Epilepsy: Clinical and EEG Findings of a Placebo controlled Trial. Epilepsia 2007; 48(2): 366-74.
31. Politi E, Fauci E, Santoro A, Smeraldi E. Daily sessions of transcranial magnetic stimulation to the left prefrontal cortex gradually reduce cocaine craving. Am J Addict 2008; 17(4): 345-6.
32. Machado S, Velasques B, Paes F, et al. Transcranial magnetic stimulation: applications for stroke rehabilitation. Rev Neuroci 2011; 19(2): 339-48.
33. Rosa MA, Odebrecht M, Rigonatti SP, Marcolin MA. Eletroconvulsoterapia e estimulacao magnetica transcraniana: semelhancas e diferencas. Rev Psiquiatr Clin 2004; 31(5): 243-50.
34. Dell' Osso B, Altamura AC, Allen A, Hollander E. Brain stimulation techniques in the treatment of obsessive-compulsive disorder: current and future directions. CNS Spectr 2005; 10(12): 1966.
35. Hallett M. Transcranial magnetic stimulation: a primer. Neuron 2007; 55: 187-99.
36. Machado S, Paes F, Velasques B, et al. Is rTMS an effective therapeutic strategy that can be used to treat anxiety disorders?. Neuropharmacology 2012; 62(1): 125-34.
37. Paes F, Machado S, Arias-Carrion O, et al. The value of repetitive transcranial magnetic stimulation (rTMS) for the treatment of anxiety disorders: an integrative review. CNS Neurol Disord Drug Targets 2011; 10(5): 610-20.
38. Machado S, Bittencourt J, Minc D, et al. Therapeutic applications of repetitive transcranial magnetic stimulation in clinical neurorehabilitation. Funct Neurol 2008; 23(3): 113-22.
39. Barker AT, Jalinous R, Freeston IL. Non-invasive magnetic stimulation of human motor cortex. Lancet 1985; 1: 1106-7.
40. Walsh V, Rushworth M. A primer of magnetic stimulation as a tool for neuropsychology. Neuropsychologia 1999; 37(2): 125-35.
41. Pascual-Leone A, Walsh V, Rothwell J. Transcranial magnetic stimulation in cognitive neuroscience-virtual lesion, chronometry, and functional connectivity. Curr Opin Neurobiol 2000; 10(2): 232- 7.
42. Terao Y, Ugawa Y, Suzuki M, et al. Shortening of simple reaction time by peripheral electrical and submotor-threshold magnetic cortical stimulation. Exp Brain Res 1997; 115(3): 541-5.
43. Wagner T, Gangitano M, Romero R, et al. Intracranial measurement of current densities induced by transcranial magnetic stimulation in the human brain. Neurosci Lett 2004; 354(2): 91-4.
44. Salinas FS, Lancaster JL, Fox PT. 3D modeling of the total electric field induced by transcranial magnetic stimulation using the boundary element method. Phys Med Biol 2009; 54(12): 3631-47.
45. Roth Y, Amir A, Levkovitz Y, Zangen A. Three-dimensional distribution of the electric field induced in the brain by transcranial magnetic stimulation using figure-8 and deep H-coils. J Clin Neurophysiol 2007; 24(1): 31-8.
46. Nagarajan SS, Durand DM. A generalized cable equation for magnetic stimulation of axons. Biomed Eng 1996; 43(3): 304-12.
47. Rotem A, Moses E. Magnetic stimulation of one-dimensional neuronal cultures. Biophys J 2008; 94(12): 5065-78.
48. Bohning DE, Pecheny AP, Epstein CM, et al. Mapping transcranial magnetic stimulation (TMS) fields in vivo with MRI. Neuroreport 1997; 8(11): 2535-8.
49. Stokes MG, Chambers CD, Gould IC, et al. Distance-adjusted motor threshold for transcranial magnetic stimulation. Clin Neurophysiol 2007; 118(7): 1617-25.
50. Cukic M, Kalauzi A, Ilic T, Miskovic M, Ljubisavljevic M. The influence of coil-skull distance on transcranial magnetic stimulation motor-evoked responses. Exp Brain Res 2009; 192(1): 53-60.
51. Zangen A, Roth Y, Voller B, Hallett M. Transcranial magnetic stimulation of deep brain regions: evidence for efficacy of the Hcoil. Clin Neurophysiol 2005; 116(4): 775-9.
52. Pitcher D, Walsh V, Yovel G, Duchaine B. TMS evidence for the involvement of the right occipital face area in early face processing. Curr Biol 2007; 17(18): 1568-73.
53. McConnell KA, Nahas Z, Shastri A, et al. The transcranial magnetic stimulation motor threshold depends on the distance from coil to underlying cortex: a replication in healthy adults comparing two methods of assessing the distance to cortex. Biol Psychiatry 2001; 49(5): 454-9.
54. Paus T, Jech R, Thompson CJ, Comeau R, Peters T, Evans AC. Transcranial magnetic stimulation during positron emission tomography: a new method for studying connectivity of the human cerebral cortex. J Neurosci 1997; 17(9): 3178-84.
55. Rossi S, Hallett M, Rossini PM, Pascual-Leone A. Safety of TMS Consensus Group. Safety, ethical considerations, and application guidelines for the use of transcranial magnetic stimulation in clinical practice and research. Clin Neurophysiol 2009; 120(12): 2008-39.
56. Devanne H, Lavoie BA, Capaday C. Input-output properties and gain changes in the human corticospinal pathway. Exp Brain Res 1997; 114(2): 329-38.
57. Deblieck C, Thompson B, Iacoboni M, Wu AD. Correlation between motor and phosphene thresholds: a transcranial magnetic stimulation study. Human Brain Mapping 2008; 29(6): 662-70.
58. Arias-Carrion O, Machado S, Paes F, et al. Is rTMS an effective therapeutic strategy that can be used to treat Parkinson's disease? CNS Neurol Disord Drug Targets 2011; 10(6): 693-702.
59. Schluter ND, Rushworth MF, Mills KR. Passingham RE. Signal-, set-, and movement-related activity in the human premotor cortex. Neuropsychologia 1999; 37(2): 233-43.
60. Devlin JT, Matthews PM, Rushworth MF. Semantic processing in the left inferior prefrontal cortex: a combined functional magnetic resonance imaging and transcranial magnetic stimulation study. J Cogn Neurosci 2003; 15(1): 71-84.
61. O'Shea J, Muggleton NG, Cowey A, Walsh V. Timing of target discrimination in human frontal eye fields. J Cogn Neurosci 2004; 16(6): 1060-7.
62. Feltenstein MW, See RE. The neurocircuitry of addiction: an overview. Br J Pharmacol 2008; 154(2): 261-74.
63. Di Chiara G, Bassareo V, Fenu S, et al. Dopamine and drug addiction: the nucleus accumbens shell connection. Neuropharmacology 2004; 47: 227-41.
64. Weiss F, Parsons LH, Schulteis G, et al. Ethanol selfadministration restores withdrawal-associated deficiencies in accumbal dopamine and 5-hydroxytryptamine release in dependent rats. J Neurosci 1996; 16(10): 3474-85.
65. Volkow ND, Fowler JS, Wang GJ. The addicted human brain: insights from imaging studies. J Clin Investig 2003; 111: 1444-51.
66. Koob G, Le Moal M. Addiction and the brain antireward system. Annu Rev Psychol 2008; 59: 29-53.
67. White FJ, Wang RY. Electrophysiological evidence for the existence of both D-1 and D-2 dopamine receptors in the rat nucleus accumbens. J Neurosci 1986; 6(1): 274-80.
68. Edwards S, Koob GF. Neurobiology of dysregulated motivational systems in drug addiction. Fut Neurol 2010; 5(3): 393-410.
69. Arias-Carrion O, Stamelou M, Murillo-Rodriguez E, Menendez- Gonzalez M, Poppel E. Dopaminergic reward system: a short integrative review. Int Arch Med 2010; 3: 24.
70. Gottlieb DI. GABAergic neurons. Sci Am 1988; 258(2): 82-9.
71. Nestler EJ. Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci 2001; 2(2): 119-28.
72. Kalivas PW, O'Brien C. Drug addiction as a pathology of staged neuroplasticity. Neuropsychopharmacol Rev 2008; 3,166-80.
73. Dong Y, Nasif FJ, Tsui JJ, et al. Cocaine-induced plasticity of intrinsic membrane properties in prefrontal cortex pyramidal neurons: adaptations in potassium. J Neurosci 2005; 25(4): 936-40.
74. Volkow ND, Wang GJ, Fowler JS, Telang F. Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology. Phil Trans R Soc B Biol Sci 2008; 363(1507): 3191-200.
75. Koob G, Kreek MJ. Stress, dysregulation of drug reward pathways, and the transition to drug dependence. Am J Psychiatry 2007; 164(8): 1149-59.
76. Nestler EJ. Is there a common molecular pathway for addiction? Nat Neurosci 2005; 8(11): 1445-9.
77. Kalivas PW, Volkow ND. The neural basis of addiction: a pathology of motivation and choice. Am J Psychiatry 2005; 162(8): 1403-13.
78. Carobrez ADP. Glutamatergic neurotransmission as molecular target in anxiety. Rev Bras Psiquiatr 2003; 25: 52-8.
79. Solomon RL, Corbit JD. An opponent-process theory of motivation: I. Temporal dynamics of affect. Psychol Rev 1974; 81(2): 119.
80. Volkow ND, Fowler JS, Wang GJ, et al. Cognitive control of drug craving inhibits brain reward regions in cocaine abusers. Neuroimage 2010; 49(3): 2536-43.
81. Weiss RD, Griffin ML, Mazurick C, et al. The relationship between cocaine craving, psychosocial treatment, and subsequent cocaine use. Am J Psychiatry 2003; 160: 7.
82. Pallanti S, Bernardi S. Neurobiology of repeated transcranial magnetic stimulation in the treatment of anxiety: a critical review. Int Clin Psychopharmacol 2009; 24(4): 163-73.
83. Brody AL, Cook IA. Manipulation of cigarette craving with transcranial magnetic stimulation. Biol Psychiatry 2011; 70(8): 702.
84. Ernst M, Paulus MP. Neurobiology of decision making: a selective review from a neurocognitive and clinical perspective. Biol Psychiatry 2005; 58(8): 597-604.
85. Fecteau S, Leone AP, Zald DH, et al. Activation of prefrontal cortex by transcranial direct current stimulation reduces appetite for risk during ambiguous decision making. J Neurosci 2007; 27(23): 6212-8.
86. Volkow ND, Fowler JS, Wang GJ, Swanson JM, Telang F. Dopamine in Drug Abuse and Addiction, Results of Imaging Studies and Treatment Implications. Arch Neurol 2007; 64(11): 1575-9.
87. Amiaz R, Levy D, Vainiger D, Grunhaus L, Zangen A. Repeated high-frequency transcranial magnetic stimulation over the dorsolateral prefrontal cortex reduces cigarette craving and consumption. Addiction 2009; 104: 653-60.
88. Erhardt A, Sillaber I, Welt T, Muller MB, Singewald N, Keck ME. Repetitive transcranial magnetic stimulation increases the release of dopamine in the nucleus accumbens shell of morphine-sensitized rats during abstinence. Neuropsychopharmacology 2004; 29: 2074- 80.
89. Keck ME, Welt T, Muller MB, et al. Repetitive transcranial magnetic stimulation increases the release of dopamine in the mesolimbic and mesostriatal system. Neuropharmacology 2002; 43: 101-9.
90. Strafella AP, Paus T, Barrett J, Dagher A. Repetitive transcranial magnetic stimulation of the human prefrontal cortex induces dopamine release in the caudate nucleus. J Neurosci 2001; 21: RC157.
91. Johann M, Wiegand R, Kharraz A, et al. Transkranielle magnetstimulation bei nikotinabhangigkeit.Sychiatr Praxis 2003; 30(S2): 129-31.
92. Li X, Hartwell KJ, Owens M, et al. Repetitive transcranial magnetic stimulation of the dorsolateral prefrontal cortex reduces nicotine cue craving. Biol Psychiatry 2013; 73(8): 714-20.
93. Wing VC, Bacher I, Wu BS, Daskalakis ZJ, George TP. High frequency repetitive transcranial magnetic stimulation reduces tobacco craving in schizophrenia. Schizophr Res 2012; 139(1): 264-6.
94. Sheffer CE, Mennemeier M, Landes RD, et al. Neuromodulation of delay discounting, the reflection effect, and cigarette consumption. J Subst Abuse Treatm 2013; 45(2): 206-14.
95. Wing VC, Barr MS, Wass CE, et al. Brain stimulation methods to treat tobacco addiction. Brain Stimul 2013; 6(3): 221-30.
96. Rose JE, McClernon FJ, Froeliger B, Behm FM, Preud'homme X, Krystal AD. Repetitive transcranial magnetic stimulation of the superior frontal gyrus modulates craving for cigarettes. Biol Psychiatry 2011; 70(8): 794-9.
97. Herremans SC, Baeken C, Vanderbruggen N, et al. No influence of one right-sided prefrontal HF-rTMS session on alcohol craving in recently detoxified alcohol-dependent patients: results of a naturalistic study. Drug Alcohol Depend 2012; 120(1): 209-13.
98. Mishra BR, Nizamie SH, Das B, Praharaj SK. Efficacy of repetitive transcranial magnetic stimulation in alcohol dependence: a sham controlled study. Addiction 2010; 105(1): 49-55.
99. Hoppner J, Broese T, Wendler L, Berger C, Thome J. Repetitive transcranial magnetic stimulation (rTMS) for treatment of alcohol dependence. World J Biol Psychiatry 2011; 12(S1): 57-62.
100. Uher R, Yoganathan D, Mogg A, et al. Effect of left prefrontal repetitive transcranial magnetic stimulation on food craving. Biol Psychiatry 58(10): 840-2.
101. Barth KS, Rydin-Gray S, Kose S, et al. Food cravings and the effects of left prefrontal repetitive transcranial magnetic stimulation using an improved sham condition. Front Psychiatry 2011; 2: 9.
102. Van den Eynde F, Claudino AM, Mogg A, et al. Repetitive transcranial magnetic stimulation reduces cue-induced food craving in bulimic disorders. Biol Psychiatry 2010; 67(8): 793-5.
103. Walpoth M, Hoertnagl C, Mangweth-Matzek B, et al. Repetitive transcranial magnetic stimulation in bulimia nervosa: preliminary results of a single-centre, randomised, double-blind, shamcontrolled trial in female outpatients. Psychother Psychosomat 2007; 77(1): 57-60.
104. Rosenberg O, Klein LD, Dannon PN. Deep transcranial magnetic stimulation for the treatment of pathological gambling. Psychiatry Res 2013; 206: 111-3.